Description

Elobopa 25mg Tablet (Eltrombopag) Uses, Side Effects, Dosage & Price in Pakistan

Elobopa 25mg Tablet (Eltrombopag) is a prescription medicine used to increase platelet production in patients with certain blood disorders. It contains eltrombopag, which belongs to a class of medicines known as thrombopoietin receptor agonists (TPO-RAs).

Eltrombopag stimulates cells in the bone marrow to produce more platelets. Platelets are blood cells that help the body form clots and control bleeding. The medicine may be prescribed when platelet levels remain too low and other treatments are unsuitable or have not produced an adequate response.

Elobopa should only be used under the supervision of a hematologist or other qualified healthcare professional because regular blood tests and liver monitoring may be required during treatment.

Patients searching for Elobopa 25mg Tablet in Pakistan can contact Impo Medic for current price, availability, and sourcing information.

Elobopa 25mg Tablet (Eltrombopag) Used

Eltrombopag is used for selected conditions involving low platelet counts or impaired blood-cell production.

Depending on the patient’s diagnosis and clinical circumstances, eltrombopag may be prescribed for:

• Persistent or chronic immune thrombocytopenia (ITP)
• Severe aplastic anemia
• Selected patients with thrombocytopenia associated with chronic hepatitis C treatment, depending on treatment setting and applicable medical guidance

In immune thrombocytopenia, the platelet count can become low enough to increase the risk of bruising or bleeding.

In aplastic anemia, the bone marrow does not produce enough new blood cells. Eltrombopag can be used in certain patients as part of specialist management.

The medicine is not intended simply to make platelet counts normal. Treatment is generally aimed at achieving a platelet level that helps reduce the risk of bleeding while limiting unnecessary exposure to higher doses.

How Does Elobopa 25mg Tablet Work?

Elobopa 25mg Tablet contains eltrombopag, a thrombopoietin receptor agonist.

Thrombopoietin is involved in regulating platelet production. Eltrombopag interacts with the thrombopoietin receptor and stimulates processes that promote the growth and development of megakaryocytes, the bone-marrow cells responsible for producing platelets.

As a result, platelet production can increase.

The response is not immediate, and platelet counts must be monitored through blood tests. Dose adjustments are usually based on the patient’s platelet response and clinical condition.

Elobopa 25mg Tablet Dosage

The correct eltrombopag dose varies significantly according to:

• Condition being treated
• Patient’s age
• Platelet count
• Liver function
• Treatment response
• Ethnic background in certain prescribing recommendations
• Other medicines being taken

For some adults with persistent or chronic ITP, eltrombopag treatment may begin at 50mg once daily, while a lower starting dose such as 25mg once daily may be recommended for certain patients, including those with hepatic impairment or in specific population groups.

Aplastic anemia treatment can require a different dosing strategy.

Therefore, Elobopa 25mg Tablet should not be self-dosed. A hematologist should determine the starting dose and adjust it according to platelet counts and safety monitoring.

Never increase the dose simply because the platelet count remains low after only a few doses.

How to Take Elobopa 25mg Tablet

Eltrombopag has important administration requirements because certain minerals can substantially reduce its absorption.

Take the tablet exactly according to the prescribed schedule.

Eltrombopag should generally be separated from products containing polyvalent cations, including:

• Calcium
• Iron
• Magnesium
• Aluminum
• Zinc
• Selenium

This includes some antacids, mineral supplements, and calcium-rich foods.

A commonly recommended approach is to take eltrombopag at least 2 hours before or 4 hours after antacids, mineral supplements, or foods containing substantial amounts of calcium.

This timing is important because taking these products too close to eltrombopag can reduce how much medicine the body absorbs.

Follow your doctor’s instructions regarding meals and dosing time carefully.

Benefits of Elobopa 25mg Tablet

For appropriately selected patients, eltrombopag may help:

• Increase platelet production
• Reduce the risk associated with severely low platelet counts
• Support management of persistent or chronic ITP
• Support treatment of severe aplastic anemia
• Reduce dependence on some other interventions in selected patients

Treatment response differs between patients. Regular blood testing is essential to determine whether the medicine is working and whether the dose needs adjustment.

Elobopa 25mg Tablet Side Effects

Like other prescription medicines, Elobopa 25mg Tablet (Eltrombopag) can cause side effects.

Possible adverse effects may include:

• Headache
• Tiredness
• Nausea
• Diarrhea
• Cough
• Fever
• Changes in liver test results

The exact side effects can vary according to the underlying condition and other treatments being used.

Patients should report persistent or unusual symptoms to their healthcare professional.

Liver Problems and Eltrombopag

Liver toxicity is an important safety consideration with eltrombopag.

The medicine can cause abnormal liver tests and, in some cases, serious liver injury. Liver function should therefore be assessed according to the treatment protocol before and during therapy.

Contact a healthcare professional promptly if symptoms such as the following develop:

• Yellowing of the skin or eyes
• Dark urine
• Unusual or severe tiredness
• Pain in the upper-right abdomen
• Abdominal swelling
• Confusion

Patients with existing liver disease require particularly careful assessment.

Risk of Blood Clots

Although eltrombopag is used to increase platelet counts, excessively increased platelets are not the treatment goal.

Blood clots can occur during treatment, particularly in patients who already have risk factors.

Symptoms requiring urgent medical assessment can include:

• Pain or swelling in one leg
• Sudden shortness of breath
• Chest pain
• Coughing up blood
• Sudden weakness or numbness
• Difficulty speaking
• Sudden changes in vision

Platelet counts should be monitored regularly so the dose can be adjusted appropriately.

Eye and Cataract Monitoring

Cataracts have been observed in association with eltrombopag treatment.

Depending on the patient’s risk factors and treatment plan, the healthcare professional may recommend an eye examination before treatment and appropriate monitoring during therapy.

Patients should report blurred vision, cloudy vision, or other significant visual changes.

Drug and Food Interactions

One of the most important practical issues with Elobopa 25mg Tablet is its interaction with minerals.

Antacids containing calcium, aluminum, or magnesium and supplements containing iron, calcium, zinc, or selenium can interfere with eltrombopag absorption.

High-calcium foods can also affect absorption when consumed too close to the dose.

Patients should provide their doctor or pharmacist with a complete list of:

• Prescription medicines
• Non-prescription medicines
• Antacids
• Vitamins
• Calcium supplements
• Iron supplements
• Herbal products
• Other nutritional supplements

Do not change another medicine or supplement solely to accommodate Elobopa without professional advice.

Monitoring During Elobopa Treatment

Regular monitoring is an important part of eltrombopag therapy.

Doctors may monitor:

• Platelet count
• Complete blood count
• Liver function
• Treatment response
• Symptoms of thrombosis
• Eye health when appropriate

Platelet counts may initially be checked frequently while the appropriate dose is being established.

Monitoring may also continue after treatment is discontinued because platelet counts can fall again after stopping eltrombopag.

Patients should attend scheduled laboratory tests even when they feel well.

Pregnancy and Breastfeeding

Patients who are pregnant, planning pregnancy, or breastfeeding should discuss this with their healthcare professional before using eltrombopag.

The potential benefits and risks need to be assessed individually.

Women who can become pregnant should follow their healthcare professional’s advice regarding contraception during treatment and for the recommended period after the final dose.

Patients should not start or stop Elobopa during pregnancy without specialist medical advice.

Elobopa 25mg Tablet Price in Pakistan

The Elobopa 25mg Tablet price in Pakistan may vary according to supplier, pack size, availability, import conditions, and market changes.

Because medicine prices can change, customers should confirm the latest price instead of relying on an old fixed amount published online.

Patients and caregivers can contact Impo Medic to inquire about the current Elobopa 25mg Tablet price in Pakistan and sourcing information.

When obtaining a prescription hematology medicine, product authenticity, correct strength, packaging condition, batch information, and expiry date should be considered alongside price.

Elobopa 25mg Tablet Availability in Pakistan

Elobopa 25mg Tablet availability in Pakistan can vary according to supplier stock and market conditions.

Specialty hematology medicines may not always be available through every local pharmacy, particularly when a particular brand or strength is required.

Patients prescribed Elobopa can contact Impo Medic to inquire about its current availability and sourcing options in Pakistan.

When checking availability, provide the complete product details:

Elobopa 25mg Tablet (Eltrombopag)

This helps ensure that the correct product and strength are identified.

How to Buy Elobopa 25mg Tablet in Pakistan

Patients and caregivers looking to buy Elobopa 25mg Tablet in Pakistan can contact Impo Medic for current information regarding price, availability, and sourcing.

Before obtaining the medicine, verify:

• Product name
• 25mg strength
• Active ingredient
• Pack details
• Batch information
• Expiry date
• Packaging condition

Elobopa is a prescription medicine and should only be used according to a hematologist or other qualified healthcare professional’s treatment plan.

Why Choose Impo Medic?

Impo Medic helps patients and caregivers in Pakistan find information about specialty, imported, prescription, oncology, and hematology medicines that may be difficult to locate through routine medicine channels.

For patients searching for Elobopa 25mg Tablet price in Pakistan, current availability, or sourcing information, Impo Medic can help with product-related inquiries.

With medicines such as eltrombopag, obtaining the correct strength and following the prescribed treatment plan are especially important because the dose may change according to platelet counts and laboratory results.

Impo Medic provides medicine availability information while encouraging patients to continue appropriate medical supervision and laboratory monitoring.

Storage Instructions

Store Elobopa according to the manufacturer’s instructions printed on the original packaging.

General medicine-storage precautions include:

• Keep tablets in their original container
• Store away from excessive heat and moisture
• Keep out of the reach of children
• Do not use tablets after their expiry date
• Avoid using medicine with damaged or questionable packaging

Follow any additional storage instructions supplied with the specific Elobopa pack.

Frequently Asked Questions

What is Elobopa 25mg Tablet (Eltrombopag) used for?

Eltrombopag is a thrombopoietin receptor agonist used for selected patients with low platelet counts, including certain patients with persistent or chronic immune thrombocytopenia, and for certain patients with severe aplastic anemia.

Does Elobopa increase platelets?

Yes. Eltrombopag stimulates the thrombopoietin receptor and promotes platelet production in the bone marrow. The response should be monitored through regular blood tests.

Is Elobopa 25mg Tablet a steroid?

No. Eltrombopag is not a steroid. It belongs to a group of medicines called thrombopoietin receptor agonists.

Can I take Elobopa with milk?

Timing matters. Calcium-rich foods such as dairy products can reduce eltrombopag absorption when consumed too close to the dose. Follow the prescribed separation period for calcium-containing foods and supplements.

Can I take calcium or iron supplements with Elobopa?

They should not generally be taken at the same time. Eltrombopag is commonly separated from mineral supplements and antacids by taking it at least 2 hours before or 4 hours after products containing polyvalent cations.

Can Elobopa affect the liver?

Yes. Eltrombopag can cause liver abnormalities and potentially serious liver injury. Liver tests may therefore be required before and during treatment.

Can Elobopa cause blood clots?

Blood clots are a recognized risk. Doctors monitor platelet counts and other risk factors to reduce unnecessary increases in platelet levels.

Should I stop Elobopa when my platelet count improves?

Do not stop, increase, or reduce the medicine without consulting your healthcare professional. The dose is adjusted according to platelet counts and clinical response.

What is Elobopa 25mg Tablet price in Pakistan?

The price can vary according to current stock, supplier, pack size, and market conditions. Contact Impo Medic for current Elobopa price and availability information in Pakistan.

Where can I buy Elobopa 25mg Tablet in Pakistan?

Patients and caregivers can contact Impo Medic to inquire about Elobopa 25mg Tablet availability and sourcing in Pakistan. The medicine should be used under specialist medical supervision.